CHALK RIVER, Ontario, Oct. 31, 2019 (GLOBE NEWSWIRE) — Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, is pleased to announce that it is building on its 70-year history in medical isotope production and research to advance the availability and scientific understanding of actinium-225, a rare medical isotope that has shown great […]
Monthly Archives: March 2020
CNL Turns Its Attention to Next-Generation of Medical Isotopes
Cyclotron-based gallium-68 generator breaks production records
November 26, 2019 – Gallium-68 (68Ga) is a positron emitter that’s becoming established as a valuable diagnostic isotope, primarily for detection of neuroendocrine tumours (NETs). Such tumours do not metabolize glucose well – precluding their visualization via standard FDG-PET scans – but overexpress somatostatin receptors that bind, for example, to the PET agent 68Ga-Dotatate. Currently, 68Ga is […]
Chuck Conroy Appointed CEO of ARTMS
VANCOUVER, British Columbia-September 10, 2019 -ARTMS Products Inc., the global leader in the innovation and commercialization of novel technologies that enable cyclotron production of the world’s most needed medical radioisotopes, is pleased to announce the appointment of Charles S. Conroy R.Ph, MBA as its Chief Executive Officer. Mr. Conroy brings to ARTMS more than 25 […]
ARTMS Products Received $1.5 Million of Funding from the Federal Government
VANCOUVER, British Columbia–August 14, 2019– ARTMS Products Inc., a global leader in the development and commercialization of novel technologies and products that enable cyclotron production of the world’s most needed medical radioisotopes, is pleased to announce they have received $1.5 million funding from Western Economic Diversification Canada as part of its Business Scale-up and Productivity […]
Australian isotope facility to begin full-scale operations
June 13, 2019 – The ANSTO Nuclear Medicine (ANM) facility has received a regulatory licence that will allow it to move to full production of molybdenum-99 (Mo-99), the Australian nuclear science and technology organisation announced today. Limited manufacturing of the isotope began in April after the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) amended […]
Three US firms awarded Mo-99 production funds
July 23, 2019 – The US Department of Energy’s National Nuclear Security Administration (NNSA) has awarded cooperative agreements for the production of molybdenum-99 to three US companies. The announcement came as one of the companies – Shine Medical Technologies – submitted an application to the Nuclear Regulatory Commission (NRC) to produce medical isotopes at its […]
Israeli researchers develop inexpensive method to produce nuclear medicine isotopes
JERUSALEM, June 5, 2019 — Israeli researchers have developed a new efficient and inexpensive method of producing radioactive isotopes for nuclear medicine and imaging technologies such as CT and PET CT scans. The development was reported by the southern Ben-Gurion University on Wednesday. Isotopes are types of the same chemical element, which differ in their […]
BWXT successfully demonstrates labeling of cold kits with its technology
LYNCHBURG, Va. (WSET) — BWX Technologies, Inc. announced Tuesday, Feb. 25 that it has successfully labeled technetium-99m (Tc-99m) derived from its proprietary molybdenum-99 (Mo-99) production process and its proprietary Tc-99m generators with nine of the most widely used cold kits in the North American market. As the company announced in 2018, BWXT’s proprietary technology features […]